ImmuCell Corporation
ICCC
$9.89
-$0.02-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 265.55% | 34.18% | -653.65% | 80.09% | 132.77% |
| Total Depreciation and Amortization | -29.57% | -21.85% | 4.82% | 0.59% | -0.42% |
| Total Amortization of Deferred Charges | -70.37% | -70.37% | -70.37% | 174.07% | 0.00% |
| Total Other Non-Cash Items | 1,149.52% | 704.71% | 8,683.90% | -330.92% | -72.30% |
| Change in Net Operating Assets | 12.73% | 263.42% | 82.58% | -149.95% | -70.53% |
| Cash from Operations | 88.52% | 127.03% | 15,664.52% | -84.98% | 175.27% |
| Capital Expenditure | -372.87% | 46.16% | 12.18% | -571.83% | -40.20% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | 548.89% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -482.92% | 49.19% | 14.73% | -569.68% | -18.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.53% | -5.24% | -5.45% | -205.27% | -4.67% |
| Issuance of Common Stock | -49.98% | -100.00% | -100.00% | -100.00% | -21.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 86.82% | 84.89% |
| Cash from Financing | -210.99% | 0.89% | -365.01% | -110.51% | 31.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.35% | 257.37% | -57.54% | -185.03% | 284.47% |